A detailed history of Barclays PLC transactions in Danaher Corp stock. As of the latest transaction made, Barclays PLC holds 3,120,751 shares of DHR stock, worth $727 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,120,751
Previous 3,120,751 -0.0%
Holding current value
$727 Million
Previous $868 Million -0.0%
% of portfolio
0.23%
Previous 0.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$239.25 - $280.76 $37.7 Million - $44.3 Million
157,634 Added 5.32%
3,120,751 $868 Million
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $11.2 Million - $12.8 Million
47,717 Added 1.64%
2,963,117 $740 Million
Q1 2024

May 15, 2024

BUY
$224.58 - $256.19 $48.5 Million - $55.4 Million
216,177 Added 8.01%
2,915,400 $728 Million
Q4 2023

Feb 15, 2024

BUY
$185.1 - $233.13 $13.7 Million - $17.2 Million
73,924 Added 2.82%
2,699,223 $624 Million
Q3 2023

Nov 07, 2023

BUY
$233.08 - $265.59 $46.9 Million - $53.4 Million
201,027 Added 8.29%
2,625,299 $651 Million
Q2 2023

Aug 03, 2023

BUY
$224.99 - $256.14 $172 Million - $196 Million
764,165 Added 46.03%
2,424,272 $582 Million
Q1 2023

May 04, 2023

SELL
$239.75 - $277.0 $93.4 Million - $108 Million
-389,543 Reduced 19.01%
1,660,107 $418 Million
Q4 2022

Feb 13, 2023

SELL
$241.42 - $282.29 $43.8 Million - $51.2 Million
-181,458 Reduced 8.13%
2,049,650 $544 Million
Q3 2022

Nov 03, 2022

BUY
$247.06 - $1507.4 $80.8 Million - $493 Million
327,041 Added 17.18%
2,231,108 $576 Million
Q2 2022

Aug 12, 2022

SELL
$237.11 - $299.66 $94.6 Million - $120 Million
-399,015 Reduced 17.33%
1,904,067 $483 Million
Q1 2022

May 16, 2022

SELL
$257.27 - $315.76 $237 Million - $291 Million
-922,925 Reduced 28.61%
2,303,082 $676 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $268 Million - $301 Million
916,102 Added 39.66%
3,226,007 $1.06 Billion
Q3 2021

Nov 09, 2021

BUY
$272.21 - $332.43 $139 Million - $170 Million
510,323 Added 28.36%
2,309,905 $703 Million
Q2 2021

Aug 13, 2021

BUY
$225.08 - $271.69 $26.7 Million - $32.2 Million
118,613 Added 7.06%
1,799,582 $483 Million
Q1 2021

May 13, 2021

BUY
$212.38 - $245.9 $38.1 Million - $44.2 Million
179,575 Added 11.96%
1,680,969 $378 Million
Q4 2020

Feb 11, 2021

SELL
$212.5 - $245.46 $215 Million - $248 Million
-1,012,076 Reduced 40.27%
1,501,394 $334 Million
Q3 2020

Nov 12, 2020

BUY
$177.16 - $215.33 $207 Million - $252 Million
1,167,978 Added 86.81%
2,513,470 $541 Million
Q2 2020

Aug 12, 2020

SELL
$128.7 - $176.83 $60.5 Million - $83.1 Million
-470,049 Reduced 25.89%
1,345,492 $238 Million
Q1 2020

May 13, 2020

BUY
$121.39 - $169.05 $14 Million - $19.4 Million
114,980 Added 6.76%
1,815,541 $251 Million
Q4 2019

Feb 10, 2020

BUY
$133.47 - $153.48 $13.6 Million - $15.6 Million
101,526 Added 6.35%
1,700,561 $261 Million
Q3 2019

Nov 14, 2019

SELL
$135.4 - $146.47 $1.67 Million - $1.81 Million
-12,327 Reduced 0.77%
1,599,035 $231 Million
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $22 Million - $25.3 Million
175,788 Added 12.25%
1,611,362 $230 Million
Q1 2019

May 15, 2019

SELL
$97.62 - $132.29 $12.1 Million - $16.4 Million
-123,738 Reduced 7.94%
1,435,574 $190 Million
Q4 2018

Feb 14, 2019

SELL
$94.85 - $109.54 $1.82 Million - $2.1 Million
-19,141 Reduced 1.21%
1,559,312 $161 Million
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $9.72 Million - $10.8 Million
99,049 Added 6.7%
1,578,453 $172 Million
Q2 2018

Aug 14, 2018

SELL
$96.1 - $103.24 $36.4 Million - $39.1 Million
-378,827 Reduced 20.39%
1,479,404 $146 Million
Q1 2018

May 15, 2018

BUY
$92.16 - $103.8 $26.9 Million - $30.3 Million
291,947 Added 18.64%
1,858,231 $182 Million
Q4 2017

Feb 14, 2018

BUY
$85.26 - $94.62 $36.2 Million - $40.2 Million
425,159 Added 37.26%
1,566,284 $145 Million
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $90.5 Million - $101 Million
1,141,125
1,141,125 $97.9 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $170B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.